Français Register Login

  • All sections
  • A - Human necessities
  • A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • A61P 11/14 - Antitussive agents

Patent holdings for IPC class A61P 11/14

Total number of patents in this class: 409

10-year publication summary

11
14
34
17
26
39
33
28
27
28
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Boehringer Ingelheim International GmbH
4635
10
Glaxosmithkline Intellectual Property (no.2) Limited
296
10
Chiesi Farmaceutici S.p.A.
973
9
Wuhan LL Science and Technology Development Co., Ltd
72
9
Institute of Materia Medica, Chinese Academy of Medical Sciences
182
8
The Procter & Gamble Company
21989
7
Biocopea Limited
21
7
Nippon Chemiphar Co., Ltd.
232
7
Genexa Inc.
36
7
Daiichi Sankyo Company, Limited
1877
5
Shionogi & Co., Ltd.
835
5
Verona Pharma plc
110
5
The First Affiliated Hospital of Guangzhou Medical University
16
5
Guangzhou Institute of Respiratory Disease
10
5
Chengdu Shibeikang Biomedical Technology Co., Ltd.
22
5
Antecip Bioventures II LLC
347
4
Jiangsu Kanion Pharmaceutical Co., Ltd.
84
4
Trevi Therapeutics, Inc.
36
4
Salus Pharma Technology (Shanghai) Co., Ltd.
4
4
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
126
4
Other owners 285

  • ipowner home
  • ipqwery home
  • contact us
  • privacy policy
  • terms and conditions
© 2025 IPQwery All rights reserved